Toll-like receptor function and signaling

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 5, 2006, Pages 979-987

  Kaisho, Tsuneyasu ^a   Akira, Shizuo ^b,c  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

adjuvant; allergy; CpG DNA; dendritic cell; MyD88; Pattern recognition receptor; plasmacytoid dendritic cell; Toll like receptor; type I IFN

Indexed keywords

ANIMALS; HUMANS; IMMUNITY, NATURAL; LIGANDS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33646147362     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.02.023     Document Type: Review

References (60)

1. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54 (1989) 1-13
2. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 1 (2001) 135-145
3. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
4. Inohara N., and Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3 (2003) 371-382
5. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat Immunol 7 (2006) 131-137
6. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 12 (2000) 20-26
7. Miyake K. Endotoxin recognition molecules, Toll-like receptor 4-MD-2. Semin Immunol 16 (2004) 11-16
8. Wagner H. Bacterial CpG DNA activates immune cells to signal infectious danger. Adv Immunol 73 (1999) 329-368
9. Krieg A.M. The role of CpG motifs in innate immunity. Curr Opin Immunol 12 (2000) 35-43
10. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 25 (2004) 381-386
11. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
12. Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., and Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196 (2002) 1645-1651
13. Kaisho T., Hoshino K., Iwabe T., Takeuchi O., Yasui T., and Akira S. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int Immunol 14 (2002) 695-700
14. Strachan D. Hay fever, hygiene, and household size. BMJ 299 (1989) 1259-1260
15. Kim S.K., Ragupathi G., Musselli C., Choi S.J., Park Y.S., and Livingston P.O. Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines. Vaccine 18 (1999) 597-603
16. Broide D., Schwarze J., Tighe H., Gifford T., Nguyen M.D., Malek S., et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 161 (1998) 7054-7062
17. Kline J.N., Waldschmidt T.J., Businga T.R., Lemish J.E., Weinstock J.V., Thorne P.S., et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 160 (1998) 2555-2559
18. Sur S., Wild J.S., Choudhury B.K., Sur N., Alam R., and Klinman D.M. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 162 (1999) 6284-6293
19. Fanucchi M.V., Schelegle E.S., Baker G.L., Evans M.J., McDonald R.J., Gershwin L.J., et al. Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys. Am J Respir Crit Care Med 170 (2004) 1153-1157
20. Shirota H., Sano K., Kikuchi T., Tamura G., and Shirato K. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 164 (2000) 5575-5582
21. Tighe H., Takabayashi K., Schwartz D., Van Nest G., Tuck S., Eiden J.J., et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 106 (2000) 124-134
22. Hessel E.M., Chu M., Lizcano J.O., Chang B., Herman N., Kell S.A., et al. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J Exp Med 202 (2005) 1563-1573
23. Liu N., Ohnishi N., Ni L., Akira S., and Bacon K.B. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat Immunol 4 (2003) 687-693
24. Dahl M.E., Dabbagh K., Liggitt D., Kim S., and Lewis D.B. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 5 (2004) 337-343
25. Bashir M.E., Andersen P., Fuss I.J., Shi H.N., and Nagler-Anderson C. An enteric helminth infection protects against an allergic response to dietary antigen. J Immunol 169 (2002) 3284-3292
26. Wohlleben G., Trujillo C., Muller J., Ritze Y., Grunewald S., Tatsch U., et al. Helminth infection modulates the development of allergen-induced airway inflammation. Int Immunol 16 (2004) 585-596
27. Mangan N.E., van Rooijen N., McKenzie A.N., and Fallon P.G. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J Immunol 176 (2006) 138-147
28. Wilson M.S., Taylor M.D., Balic A., Finney C.A., Lamb J.R., and Maizels R.M. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 202 (2005) 1199-1212
29. Barton G.M., Kagan J.C., and Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7 (2006) 49-56
30. Edwards A.D., Diebold S.S., Slack E.M., Tomizawa H., Hemmi H., Kaisho T., et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33 (2003) 827-833
31. Gursel I., Gursel M., Yamada H., Ishii K.J., Takeshita F., and Klinman D.M. Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol 171 (2003) 1393-1400
32. Kariko K., Buckstein M., Ni H., and Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23 (2005) 165-175
33. Colonna M., Trinchieri G., and Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat Immunol 5 (2004) 1219-1226
34. Rifkin I.R., Leadbetter E.A., Busconi L., Viglianti G., and Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204 (2005) 27-42
35. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 4 (2004) 249-258
36. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005) 1035-1040
37. Kerkmann M., Costa L.T., Richter C., Rothenfusser S., Battiany J., Hornung V., et al. Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells. J Biol Chem 280 (2005) 8086-8093
38. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 (2004) 499-511
39. Kawai T., Adachi O., Ogawa T., Takeda K., and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11 (1999) 115-122
40. Suzuki N., Suzuki S., and Yeh W.C. IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol 23 (2002) 503-506
41. Horng T., Barton G.M., Flavell R.A., and Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420 (2002) 329-333
42. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420 (2002) 324-329
43. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
44. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T., et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4 (2003) 1144-1150
45. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5 (2004) 503-507
46. Couillault C., Pujol N., Reboul J., Sabatier L., Guichou J.F., Kohara Y., et al. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat Immunol 5 (2004) 488-494
47. Covert M.W., Leung T.H., Gaston J.E., and Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309 (2005) 1854-1857
48. Hemmi H., Kaisho T., Takeda K., and Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 170 (2003) 3059-3064
49. Kawai T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5 (2004) 1061-1068
50. Honda K., Yanai H., Mizutani T., Negishi H., Shimada N., Suzuki N., et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A 101 (2004) 15416-15421
51. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
52. Uematsu S., Sato S., Yamamoto M., Hirotani T., Kato H., Takeshita F., et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J Exp Med 201 (2005) 915-923
53. Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439 (2006) 208-211
54. Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.C., Wang G.G., et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439 (2006) 204-207
55. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434 (2005) 243-249
56. Negishi H., Ohba Y., Yanai H., Takaoka A., Honma K., Yui K., et al. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad Sci U S A 102 (2005) 15989-15994
57. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5 (2004) 730-737
58. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7 (2006) 40-48
59. Spies B., Hochrein H., Vabulas M., Huster K., Busch D.H., Schmitz F., et al. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J Immunol 171 (2003) 5908-5912
60. Babiuk S., Mookherjee N., Pontarollo R., Griebel P., van Drunen Littel-van den Hurk S., Hecker R., et al. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology 113 (2004) 114-120